Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy

Journal of Urology

Volumn 190, Issue 2, 2013, Pages 487-492

  Da Silva, Rodrigo Donalisio ^a,b   Xylinas, Evanguelos ^a,c   Kluth, Luis ^a,d   Crivelli, Joseph J ^a   Chrystal, James ^a   Chade, Daher ^a,b   Guglielmetti, Giuliano Betoni ^b   Pycha, Armin ^e   Lotan, Yair ^f   Karakiewicz, Pierre I ^g   Sun, Maxine ^g   Fajkovic, Harun ^h   Zerbib, Marc ^c   Scherr, Douglas S ^a   Shariat, Shahrokh F ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Paris Descartes University ^*  (France)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e CENTRAL HOSPITAL OF BOLZANO   (Italy)

^f UNIVERSITY OF TEXAS AT DALLAS   (United States)

^g UNIVERSITÉ DE MONTRÉAL   (Canada)

^h Karl Landsteiner Institute for Implementation of Innovative Techniques in Cardiac Surgery   (Austria)

Author keywords

hydroxymethylglutaryl CoA reductase inhibitors; mortality; neoplasm recurrence; urinary bladder; urinary bladder neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; BODY MASS; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CYSTECTOMY; DRUG USE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SMOKING; TRANSITIONAL CELL CARCINOMA;

BMI; BODY MASS INDEX; CARCINOMA IN SITU; CIS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LVI; LYMPHOVASCULAR INVASION; MORTALITY; NEOPLASM RECURRENCE; POSITIVE SOFT TISSUE SURGICAL MARGIN; RADICAL CYSTECTOMY; RC; STSM; UCB; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIAL CARCINOMA OF BLADDER;

AGE FACTORS; AGED; BODY MASS INDEX; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SMOKING; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84880037409     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.02.003     Document Type: Article

References (21)

1. M. Burger, W. Oosterlinck, B. Konety ICUD-EAU International Consultation on Bladder Cancer 2012: Non-Muscle-Invasive Urothelial Carcinoma of the Bladder Eur Urol 63 2013 36
2. S.F. Shariat, P.I. Karakiewicz, G.S. Palapattu Nomograms provide improved accuracy for predicting survival after radical cystectomy Clin Cancer Res 12 2006 6663
3. P.M. Ridker, A. Pradhan, J.G. MacFadyen Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial Lancet 380 2012 565
4. M. Jakóbisiak, S. Bruno, J.S. Skierski Cell cycle-specific effects of lovastatin Proc Natl Acad Sci U S A 88 1991 3628
5. K. Undela, V. Srikanth, D. Bansal Statin use and risk of breast cancer: a meta-analysis of observational studies Breast Cancer Res Treat 135 2012 261
6. S. Bonovas, K. Filioussi, N.M. Sitaras Statin use and the risk of prostate cancer: a meta-analysis of 6 randomized clinical trials and 13 observational studies Int J Cancer 123 2008 899
7. J.N. Poynter, S.B. Gruber, P.D. Higgins Statins and the risk of colorectal cancer N Engl J Med 352 2005 2184
8. R.K. Berglund, C.J. Savage, K.C. Vora An analysis of the effect of statin use on the efficacy of bacillus Calmette-Guerin treatment for transitional cell carcinoma of the bladder J Urol 180 2008 1297
9. T.A. Skolarus, E.W. Lee, K.S. Virgo Intravesical bacille Calmette-Guérin therapy for non-muscle-invasive bladder cancer: effects of concurrent statin therapy J Am Coll Surg 209 2009 248
10. H.K. Tsai, M.S. Katz, J.J. Coen Association of statin use with improved local control in patients treated with selective bladder preservation for muscle-invasive bladder cancer Urology 68 2006 1188
11. F.L. Greene AJCC Cancer Staging Manual 6th ed. 2002 Springer New York
12. J.I. Epstein, M.B. Amin, V.R. Reuter The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder Bladder Consensus Conference Committee Am J Surg Pathol 22 1998 1435
13. S.F. Shariat, R.S. Svatek, D. Tilki International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy BJU Int 105 2010 1402
14. G. Novara, R.S. Svatek, P.I. Karakiewicz Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients J Urol 183 2010 2165
15. M. Rink, H. Fajkovic, E.K. Cha Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma Eur Urol 61 2012 854
16. T.F. Chromecki, E.K. Cha, H. Fajkovic Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy BJU Int 111 2013 249
17. M.E. Nielsen, S.F. Shariat, P.I. Karakiewicz Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy Eur Urol 51 2007 699
18. M. Rink, D.J. Lee, M. Kent Predictors of cancer-specific mortality after disease recurrence following radical cystectomy BJU Int 111 2013 E30
19. A.S. Kumar, C.C. Benz, V. Shim Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users Cancer Epidemiol Biomarkers Prev 17 2008 1028
20. A.A. Siddiqui, H. Nazario, A. Mahgoub For patients with colorectal cancer, the long-term use of statins is associated with better clinical outcomes Dig Dis Sci 54 2009 1307
21. M. Lutski, V. Shalev, A. Porath Continuation with statin therapy and the risk of primary cancer: a population-based study Prev Chronic Dis 9 2012 E137